Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 40Lymphoma, Mantle-Cell 27Lymphoma 26Lymphoma, Follicular 25Lymphoma, Non-Hodgkin 23Leukemia, Lymphocytic, Chronic, B-Cell 22Lymphoma, B-Cell 14Lymphoma, B-Cell, Marginal Zone 13Burkitt Lymphoma 12Recurrence 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Neoplasms 8Waldenstrom Macroglobulinemia 6Leukemia, Hairy Cell 5Lymphoproliferative Disorders 4Leukemia 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3beta-Thalassemia 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasm, Residual 2Lymphatic Diseases 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Biphenotypic, Acute 2Leukemia, B-Cell 2Infections 2Hodgkin Disease 2Hematologic Neoplasms 2Epstein-Barr Virus Infections 2

Interventions

liposomal doxorubicin 1Zidovudine 1Vincristine 1Valganciclovir 1Sirolimus 1Rituximab 1Prednisone 1Interferon-alpha 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphadenopathy × Rituximab × 90 days × Clear all
NCT00092222 2026-06-05

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
75 enrolled
Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡